Organization | European Regional Development Fund

European Regional Development Fund Report issue

Foundation Phase 2

Founded: Brussels Belgium (1975)

Organization Overview

First Clinical Trial

2012

NCT01605383

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

European Regional Development Fund | European Regional Development Fund (FEDER) | Europees Fonds voor Regionale Ontwikkeling (EFRO)

Active Ingredients

Drugs in Phase 2 Trials (5)

autologous mesenchymal stem cells (1 trial)

bifidobacterium breve (1 trial)

kh176 (1 trial)

lactobacillus fermentum (1 trial)

simethicone (1 trial)

Drugs in Other Trials (4)

collagen (1 trial)

lutein (1 trial)

red clover extract (1 trial)

ubiquinone (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Colic (Phase 2)

Femur Head Necrosis (Phase 2)

Necrosis (Phase 2)

Osteonecrosis (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 6
# of Trial APIs: 9